First Gaucher type 3 neurological drug approved
-
By
-
Teraya Smith
-
November 18, 2026
-
2 min
By
Teraya Smith
November 18, 2026
Greater productivity is not necessarily indicative of greater knowledge.
September 10, 2026
Nearly 90% of patients who met algorithmic criteria for postacute sequelae of SARS-CoV-2 infection had at least 1 chronic or potentially chronic condition requiring ongoing clinical management.
June 30, 2026